Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03292211
Other study ID # 201706073RINB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 12, 2017
Est. completion date February 10, 2019

Study information

Verified date September 2018
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to examine the outcomes of early mobilization and early intervention within 24-72 hours after the onset of hemorrhagic stroke in patients admitted to an intensive care unit within 24 hours after stroke. The patients after hemorrhagic stroke who undergo early intervention only will be compared with those who also receive early mobilization in order to determine if the early mobilization intervention results in earlier or more effective recovery of postural stability, activities of daily living function, or motor capacity.

The participants will be randomly assigned to the following two groups: (1) the early mobilization (+early rehabilitation) group and (2) the early rehabilitation group.The measurement parameters will be collected before the intervention (basic parameters), two weeks after the stroke, four weeks after the stroke and three months after the stroke. SPSS (version 17.0) will be used to carry out repeated measures analysis of variance (repeated ANOVA) to compare the differences between the groups at different time points (including basic values and follow-up values). For statistical significance, Bonferroni correction will be applied for the post-hoc analysis of the groups.


Description:

Early intervention has been proven to enhance post-stroke functional recovery. Recent studies have proposed that early mobilization (out-of-bed activities) also contributes to an individual's functional improvement after stroke. However, studies on early intervention after stroke have mainly investigated patients with ischemic stroke, while tending to exclude patients with hemorrhagic stroke who were admitted to intensive care units. The main reason for this is the difference between hemorrhagic and ischemic strokes in terms of their mechanisms and treatment methods. Hemorrhagic stroke is characterized by higher severity and fatality rates, and there is a general lack of research on early rehabilitation and mobilization after hemorrhagic strokes. To our knowledge, there have been no previous studies that have simultaneously compared the impact of early mobilization and early rehabilitation starting at the same time on the motor recovery of patients after intracranial hemorrhage. Thus, this study aims to examine the outcomes of early mobilization and intervention within 24-72 hours after the onset of hemorrhagic stroke in patients admitted to an intensive care unit within 24 hours after stroke. The patients will be compared to identify differences in the recovery of postural stability and functional abilities two weeks, four weeks and three months after stroke.

The participants will be randomly assigned to the following two groups: (1) the early mobilization (+early rehabilitation) group and (2) the early rehabilitation group. The early mobilization group will receive early mobilization intervention within24-72 hours after stroke while being monitored by medical equipment. In early mobilization group, this intervention program will most include early out-of-bed activities (that is, rolling and sitting at the edge of the bed). The early rehabilitation group will undergo only conventional early in-bed activities in the stroke center.

All the outcome measures will be collected at baseline (pre-intervention), 2 weeks after stroke, 4 weeks after stroke and three months after stroke.The results will be analyzed with SPSS (IBM SPSS Statistics 17, Chicago, IL, USA). Repeated measures analysis of variance (repeated ANOVA) and the Chi-square test for categorical variables will be used for comparing the outcome data. If there are significant interactions, a post hoc test with Bonferroni correction will be used to examine group differences within a time condition. A p value < 0.05 will be considered statistically significant.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date February 10, 2019
Est. primary completion date November 9, 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility The inclusion criteria will be as follows:

1. patients with a first time intracerebral (either cortical or subcortical) hemorrhage with unilateral hemiparesis/ hemiplegia confirmed by magnetic resonance imaging or computed tomography;

2. patients with no contraindications to being mobilized (early intervention) within 24 hours of stroke onset (based on the medical team's clinical judgment: including systolic blood pressure (SBP)<160mmHg in resting; resting heart rate (HR)<130 bpm; no hydrocephalus; 80< mean arterial pressure (MAP)<110 mmHg before intervention);

3. patients with National Institutes of Health Stroke Scale (NIHSS) scores at admission ranging from 1 to 20;

4. patients with total activity of living independence pre-stroke; and

5. patients between 20 and 80 years old.

The exclusion criteria will be as follows:

1. patients with mild to moderate deficits as described above (3);

2. patients who are unable to complete the baseline survey because of serious aphasia, language difficulties, or cognitive deficits;

3. patients with other medical conditions, such as severe heart failure, acute coronary syndrome, or lower-limb disorders, that prevent early mobilization; and

4. patients who are unable to provide informed consent. In addition, we will exclude those showing rapid early deterioration of symptoms, as well as those with a concurrent diagnosis of rapidly deteriorating disease (e.g., terminal cancer).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
early mobilization
early out-of-bed activities including supine to sit training, sit on the edge of bed without supporting, standing with hand supporting, stepping while standing etc.within three days after stroke while being monitored by medical equipment.
early standard intervention
Conventional early in-bed activities within three days after stroke

Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary the score-change of the Functional Independence Measure (FIM) assessment for daily living function The functional independence of patient's capacities in terms of activity of daily living. The instrument assesses motor domain including dependence in self-care, sphincter management, transfer, locomotion as well as cognition domain including communication, social interaction and cognition. baseline, 2-week, 4-week and three months after stroke
Secondary the number of days required to reach a sitting>5 minutes milestone The milestone will be the ability to sit on the edge of a bed with the feet touching the floor without support > 5 minutes. baseline to within 3 months after stroke
Secondary the number of days required to reach a standing>1 minute milestone The milestone will be the ability to stand without support for longer than 1 minute and with the feet freely positioned. baseline to within 3 months after stroke
Secondary the number of days required to reach a walking>50 meters milestone using the functional ambulation category (FAC) The milestone will consist of walking on a level surface for a minimum of 50 meters with/without an assistive device while under supervision or required support level baseline to within 3 months after stroke
Secondary the number of serious adverse events Immobility-related and neurological serious adverse events include both fatal and non-fatal complications; immobility-related events include pulmonary embolism, deep-vein thrombosis, urinary tract infection, pressure sores, pneumonia; and neurological events include stroke progression and recurrent stroke. baseline to within 3 months after stroke
Secondary the score-change of the Postural Assessment Scale for Stroke Patients (PASS) 12 four-level items of varying difficulty with a maximum score of 36 baseline, 2-week, 4-week and three months after stroke
Secondary the score-change of systolic blood pressure (SBP) during the acute phase recorded the absolute SBP values over time up to 2 weeks after stroke
Secondary the number of days required to stay in the stroke center the length of stay in the stroke center baseline to within 3 months after stroke
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Completed NCT01573117 - A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1) Phase 2
Not yet recruiting NCT06069973 - Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
Not yet recruiting NCT05816213 - Point-of-care Low-field MRI in Acute Stroke
Not yet recruiting NCT05502874 - Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
Recruiting NCT04534556 - Wireless Nerve Stimulation Device To Enhance Recovery After Stroke N/A
Recruiting NCT04200781 - Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke Phase 4
Recruiting NCT05440682 - Connectivity in Cranioplasty N/A
Completed NCT05121415 - Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
Terminated NCT02626377 - Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté N/A
Completed NCT01942031 - Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke) N/A
Completed NCT01845350 - Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients Phase 1
Recruiting NCT05865795 - Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
Completed NCT04612218 - Biomarkers for Initiating Onsite and Faster Ambulance Stroke Therapies
Recruiting NCT06134921 - Effects of Transcranial Electrical Stimulation in Stroke Individuals N/A
Recruiting NCT06190314 - SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
Recruiting NCT05735405 - Aerobic Exercise and Cognitive Training in Patients With Stroke N/A
Recruiting NCT06107725 - Maimonides Minocycline in Stroke Study Phase 2/Phase 3
Completed NCT05916885 - Effects of Short-intensity Modified Constraint-induced Movement Therapy on Hand Function in Stroke Patients. N/A